![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, January 25, 2014 12:35:45 PM
Again, "the point" has to do with companies that have CE Mark and FDA approved products. The specific companies being evaluated are irrelevant.
Perhaps taking a harder look at the breast cancer epidemic in the EU and Canada is a better gage of Solos's growth in those markets. Tie this in with the differences in the US and EU/ Canadian healthcare. I bet Solos has been looking hard at this and so has a number of larger companies.
Solos's value just went up pretty high with these accreditations. That is a no brainer.
FEATURED North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • Jul 18, 2024 9:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM